Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Allogene Therapeutics Q4 EPS $(0.54) Beats $(0.60) Estimate

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 1.89 percent decrease over losses of $(0.53) per share from

byBill Haddad

February 23, 2022

1 minute read

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 1.89 percent decrease over losses of $(0.53) per share from the same period last year.